About 5-Amino-1MQ
Inhibits NNMT enzyme, increasing SAM (S-adenosylmethionine) availability. Alters adipocyte gene expression to reduce fat cell size and may increase brown adipose tissue activity via epigenetic mechanisms.
A small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor that reduces adipocyte differentiation and promotes metabolic shifts in fat cells. Not a true peptide — a synthetic quinolinium compound frequently sold alongside peptide protocols by online vendors.
Research Areas
Regulatory & Evidence
Risk Profile
Moderate risk profile in research contexts. Review contraindications and administration guidelines before use.
Regulatory Status
- Availability Status
- Research Only
Regulatory status reflects publicly available information and may change. This is not legal or medical advice.
Where to Find 5-Amino-1MQ
14 providersClinics
12 providersAdvanced Age Management
United StatesView →Anti-Aging & Longevity Medicine
United StatesView →Apex Health & Wellness
United StatesView →Cherry Hill Peptide Therapy Clinic
United StatesView →Elase
United StatesView →Hormone & Peptide Therapy Greenville SC
United StatesView →McLean Peptide Therapy Clinic
United StatesView →Optimal Wellness MD
United StatesView →Peptides
United StatesView →SA IV Center
United StatesView →Scottsdale Peptides
United StatesView →The Lamkin Clinic
United StatesView →